Alpha DaRT alpha-particle therapy, key 2026 trial catalysts, cash/dilution risks, and M&A takeover potential. See more.
Stopping GLP-1 drugs like Ozempic quickly erodes heart protection, with two years off the medication raising cardiovascular ...
GLP-1s are everywhere—but what’s fact and what’s fiction? University of Utah Health weight loss experts answer the most ...
Prosecutors in 2013 said that he killed babies who had emerged alive during late-term abortions. The case became a rallying ...
A recent study found that stopping GLP-1s, such as Ozempic or Wegovy, can reverse the cardiovascular benefits they provide.
An informational report based on publicly available materials from ReflexMD, Inc. - addressing how consumers evaluate GLP-1 ...
An informational report based on materials provided by MetaFit Pharma Solutions LLC detailing how the TrimRx telehealth platform presents its GLP-1 medication options, compounded and FDA-approved ...
TTM Technologies, Inc. is rated a Hold due to robust capital investments and a solid balance sheet. Learn more about TTMI ...
Since the Affordable Care Act subsidies expired at the end of 2025, Americans have undoubtedly been encountering a great deal ...
A new study suggests heart health gains disappear in half the time it takes to build them up when people stop taking GLP-1 ...
A Pennsylvania prison spokesperson said Gosnell died March 1 at a hospital. Prosecutors said his West Philadelphia clinic performed illegal late-term abortions.
Shares rally before February inflation at 11.30am AEDT; Rio secures Boyne Smelter future; Pepper-Challenger end talks; Amplitude Energy sinks on tests; 4D Medical’s Mayo deal. Follow live.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results